Sight Diagnostics raises another $71M to fully commercialize its blood analyzer

Sight Diagnostics raises another $71M to fully commercialize its blood analyzer

With this new cash infusion, Sight Diagnostics, which uses machine learning and AI to analyze images of blood samples, has raised a total of $124 million since its inception in 2011. 

Source: https://ift.tt/30s5ryi